The impact of genetic removal of GFAP and/or vimentin on glutamine levels and transport of glucose and ascorbate in astrocytes
- PMID: 10555775
- DOI: 10.1023/a:1022572304626
The impact of genetic removal of GFAP and/or vimentin on glutamine levels and transport of glucose and ascorbate in astrocytes
Abstract
The importance of the intermediate filament (IF) proteins glial fibrillary acidic protein (GFAP) and vimentin for astrocyte function was studied by investigating astrocytes prepared from GFAP-/- and/or vimentin-/- mice. The rate of glucose uptake through facilitative hexose transporters was not affected by depletion of GFAP or vimentin. Similarly, the absence of these IF proteins did not affect ascorbate uptake, under control or cyclic AMP-stimulated conditions, or ascorbate efflux through volume-sensitive organic anion channels. However, compared with wild-type astrocytes, glutamine concentrations were increased up to 200% in GFAP-/- astrocytes and up to 150% in GFAP+/- astrocytes and this increase was not dependent on the presence of vimentin. GFAP-/- astrocytes in culture still contain IFs (made of vimentin and nestin), whereas GFAP-/- vim-/- cultured astrocytes lack IFs. Thus, glutamine levels appear to correlate inversely with GFAP, rather than depend on the presence of IFs per se. Furthermore, the effect of GFAP is dose-dependent since the glutamine concentration in GFAP+/- astrocytes falls between those in wild-type and GFAP-/- astrocytes.
Similar articles
-
GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.Glia. 2015 Jun;63(6):1036-56. doi: 10.1002/glia.22800. Epub 2015 Mar 2. Glia. 2015. PMID: 25731615
-
Altered taurine release following hypotonic stress in astrocytes from mice deficient for GFAP and vimentin.Brain Res Mol Brain Res. 1998 Nov 12;62(1):77-81. doi: 10.1016/s0169-328x(98)00240-x. Brain Res Mol Brain Res. 1998. PMID: 9795147
-
Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression.J Neurosci. 2001 Aug 15;21(16):6147-58. doi: 10.1523/JNEUROSCI.21-16-06147.2001. J Neurosci. 2001. PMID: 11487638 Free PMC article.
-
Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system.Curr Opin Cell Biol. 2015 Feb;32:121-30. doi: 10.1016/j.ceb.2015.02.004. Epub 2015 Mar 2. Curr Opin Cell Biol. 2015. PMID: 25726916 Review.
-
Astrocytic intermediate filaments: lessons from GFAP and vimentin knock-out mice.Prog Brain Res. 2001;132:23-30. doi: 10.1016/S0079-6123(01)32062-9. Prog Brain Res. 2001. PMID: 11544992 Review. No abstract available.
Cited by
-
Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?Mol Neurodegener. 2011 Jul 30;6:55. doi: 10.1186/1750-1326-6-55. Mol Neurodegener. 2011. PMID: 21801442 Free PMC article.
-
The relative withdrawal of GFAP-An essential component of brain evolution.Front Neuroanat. 2025 Jul 17;19:1607603. doi: 10.3389/fnana.2025.1607603. eCollection 2025. Front Neuroanat. 2025. PMID: 40747269 Free PMC article.
-
Functional Recovery after Scutellarin Treatment in Transient Cerebral Ischemic Rats: A Pilot Study with (18) F-Fluorodeoxyglucose MicroPET.Evid Based Complement Alternat Med. 2013;2013:507091. doi: 10.1155/2013/507091. Epub 2013 May 2. Evid Based Complement Alternat Med. 2013. PMID: 23737833 Free PMC article.
-
Studies of pathology and pharmacology of diabetic encephalopathy with KK-Ay mouse model.CNS Neurosci Ther. 2020 Mar;26(3):332-342. doi: 10.1111/cns.13201. Epub 2019 Aug 11. CNS Neurosci Ther. 2020. PMID: 31401815 Free PMC article.
-
The effect of monosodium glutamate on the cerebellar cortex of male albino rats and the protective role of vitamin C (histological and immunohistochemical study).J Mol Histol. 2012 Apr;43(2):179-86. doi: 10.1007/s10735-011-9380-0. Epub 2011 Dec 6. J Mol Histol. 2012. PMID: 22143495
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous